Liso-cel superior to standard-of-care as second-line therapy in large B-cell lymphoma ExpertDr Manali Kamdar, University of Colorado Cancer Center, Denver, USA TrialPhase 3, TRANSFORM ConferenceASH 2021 4 February, 2022 10:28